Sex-dependent effects of early maternal deprivation on MDMA-induced conditioned place preference in adolescent rats: Possible neurochemical correlates

Toxicology

Volumn 311, Issue 1-2, 2013, Pages 78-86

  Llorente Berzal, Alvaro ^a   Manzanedo, Carmen ^b   Daza Losada, Manuel ^b   Valero, Manuel ^a   López Gallardo, Meritxell ^a   Aguilar, María A ^b   Rodríguez Arias, Marta ^b   Miñarro, José ^b   Viveros, Maria Paz ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Adolescence; CB1 receptor; Conditioned place preference; Maternal deprivation; MDMA; Serotonergic system

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 5 HYDROXYINDOLEACETIC ACID; CANNABINOID 1 RECEPTOR; CORTICOSTERONE; ENDOCANNABINOID; LEPTIN; SEROTONIN;

ADOLESCENT; ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; HIPPOCAMPUS; MALE; MATERNAL DEPRIVATION; NEUROCHEMISTRY; NEWBORN; NONHUMAN; OPEN FIELD TEST; PLACE PREFERENCE; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSYCHOBIOLOGY; RAT; REWARD; SEROTONINERGIC SYSTEM; SEX DIFFERENCE;

ADOLESCENCE; CB(1) RECEPTOR; CONDITIONED PLACE PREFERENCE; MATERNAL DEPRIVATION; MDMA; SEROTONERGIC SYSTEM;

AGING; ANIMALS; BRAIN; BRAIN CHEMISTRY; CONDITIONING, CLASSICAL; FEMALE; MALE; MATERNAL DEPRIVATION; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; RATS; RATS, WISTAR; SEX CHARACTERISTICS;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 84880812270     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2012.12.003     Document Type: Article

References (75)

1. Aguilar M.A., Rodríguez-Arias M., Miñarro J. Neurobiological mechanisms of the reinstatement of drug-conditioned place preference. Brain Res. Rev. 2009, 59:253-277.
2. Andersen S.L., Rutstein M., Benzo J.M., Hostetter J.C., Teicher M.H. Sex differences in dopamine receptor overproduction and elimination. Neuroreport 1997, 8:1495-1498.
3. Battaglia G., Yeh S.Y., O'Hearn E., Molliver M.E., Kuhar M.J., De Souza E.B. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites. J. Pharmacol. Exp. Ther. 1987, 242:911-916.
4. Battaglia G., Yeh S.Y., De Souza E.B. MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons. Pharmacol. Biochem. Behav. 1988, 29:269-274.
5. Bava S., Tapert S.F. Adolescent brain development and the risk for alcohol and other drug problems. Neuropsychol. Rev. 2010, 20:398-413.
6. Beydoun H., Saftlas A.F. Physical and mental health outcomes of prenatal maternal stress in human and animal studies: a review of recent evidence. Paediatr. Perinat. Epidemiol. 2008, 22:438-466.
7. Bilsky E.J., Reid L.D. MDL72222, a serotonin 5-HT3 receptor antagonist, blocks MDMA's ability to establish a conditioned place preference. Pharmacol. Biochem. Behav. 1991, 39:509-512.
8. Braida D., Iosuè S., Pegorini S., Sala M. 3,4 Methylenedioxymetamphetamine-induced conditioned place preference (CPP) is mediated by endocannabinoid system. Pharmacol. Res. 2005, 51:177-182.
9. Bruijnzeel A.W., Repetto M., Gold M.S. Neurobiological mechanisms in addictive and psychiatric disorders. Psychiatr. Clin. North Am. 2004, 27:661-674.
10. Campbell J., Spear L.P. Effects of early handling on amphetamine-induced locomotor activation and conditioned place preference in the adult rat. Psychopharmacology (Berl.) 1999, 143:183-189.
11. Catlow B.J., Badanich K.A., Sponaugle A.E., Rowe A.R., Song S., Rafalovich I., Sava V., Kirstein C.L., Sanchez-Ramos J. Effects of MDMA ("ecstasy") during adolescence on place conditioning and hippocampal neurogenesis. Eur. J. Pharmacol. 2010, 628:96-103.
12. Chambers R.A., Taylor J.R., Potenza M.N. Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability. Am. J. Psychiatry 2003, 160:1041-1052.
13. Cichewicz D.L., Haller V.L., Welch S.P. Changes in opioid and cannabinoid receptor protein following short-term combination treatment with delta(9)-tetrahydrocannabinol and morphine. J. Pharmacol. Exp. Ther. 2001, 297:121-127.
14. Cole J.C., Sumnall H.R. The pre-clinical behavioural pharmacology of 3,4-methylenedioxymetamphetamine (MDMA). Neurosci. Biobehav. Rev. 2003, 27:199-217.
15. Crews F., He J., Hodge C. Adolescent cortical development: a critical period of vulnerability for addiction. Pharmacol. Biochem. Behav. 2007, 86:189-199.
16. Davis J.F., Choi D.L., Schurdak J.D., Fitzgerald M.F., Clegg D.J., Lipton J.W., Figlewicz D.P., Benoit S.C. Leptin regulates energy balance and motivation through action at distinct neural circuits. Biol. Psychiatry 2011, 69:668-674.
17. Daza-Losada M., Ribeiro Do Couto B., Manzanedo C., Aguilar M.A., Rodríguez-Arias M., Miñarro J. Rewarding effects and reinstatement of MDMA induced CPP in adolescent mice. Neuropsychopharmacology 2007, 32:1750-1759.
18. Daza-Losada M., Miñarro J., Aguilar M.A., Valverde O., Rodríguez-Arias M. Acute blockade of CB1 receptor leads to reinstatement of MDMA-induced conditioned place preference. Pharmacol. Biochem. Behav. 2011, 100:33-39.
19. Egertova M., Elphick M.R. Localisation of cannabinoid receptors in the rat brain using antibodies to the intracellular C-terminal tail of CB. J. Comp. Neurol. 2000, 422:159-171.
20. EMCDDA, 2011. Annual Report 2011: The State of the Drug Problem in Europe. European Monitoring Centre for Drugs and Drug Addiction.
21. Faure J., Stein D.J., Daniels W. Maternal separation fails to render animals more susceptible to methamphetamine-induced conditioned place preference. Metab. Brain Dis. 2009, 24:541-559.
22. Ferraz-de-Paula V., Stankevicius D., Ribeiro A., Pinheiro M.L., Rodrigues-Costa E.C., Florio J.C., Lapachinske S.F., Moreau R.L., Palermo-Neto J. Differential behavioral outcomes of 3,4-methylenedioxymethamphetamine (MDMA-ecstasy) in anxiety-like responses in mice. Braz. J. Med. Biol. Res. 2011, 44:428-437.
23. Fonsart J., Menet M.C., Debray M., Hirt D., Noble F., Scherrmann J.M., Declèves X. Sprague-Dawley rats display sex-linked differences in the pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolite 3,4-methylenedioxyamphetamine (MDA). Toxicol. Appl. Pharmacol. 2009, 241:339-347.
24. Fulton S., Pissios P., Manchon R.P., Stiles L., Frank L., Pothos E.N., Maratos-Flier E., Flier J.S. Leptin regulation of the mesoaccumbens dopamine pathway. Neuron 2006, 51:811-822.
25. Graham D.L., Herring N.R., Schaefer T.L., Vorhees C.V., Williams M.T. Glucose and corticosterone changes in developing and adult rats following exposure to (+/-)-3,4-methylendioxymethamphetamine or 5-methoxydiisopropyltryptamine. Neurotoxicol. Teratol. 2010, 32:152-157.
26. Gray J.A. The Psychology of Fear and Stress. Problems in the Behavioural Sciences 1987, vol. 5. Cambridge University Press, Cambridge. second ed.
27. Grimsey N.L., Goodfellow C.E., Scotter E.L., Dowie M.J., Glass M., Graham E.S. Specific detection of CB1 receptors; cannabinoid CB1 receptor antibodies are not all created equal!. J. Neurosci. Methods 2008, 171:78-86.
28. Haj-Dahmane S., Shen R.Y. Modulation of the serotonin system by endocannabinoid signaling. Neuropharmacology 2011, 61:414-420.
29. Heffner T.G., Hartman J.A., Seiden L.S. A rapid method for the regional dissection of the rat brain. Pharmacol. Biochem. Behav. 1980, 13:453-456.
30. Kobeissy F.H., Jeung J.A., Warren M.W., Geier J.E., Gold M.S. Changes in leptin, ghrelin, growth hormone and neuropeptide-Y after an acute model of MDMA and methamphetamine exposure in rats. Addict. Biol. 2008, 13:15-25.
31. Koenig J., Lazarus C., Jeltsch H., Ben Hamida S., Riegert C., Kelche C., Jones B.C., Cassel J.C. MDMA (ecstasy) effects in pubescent rats: males are more sensitive than females. Pharmacol. Biochem. Behav. 2005, 81:635-644.
32. Kokras N., Dalla C., Sideris A.C., Dendi A., Mikail H.G., Antoniou K., Papadopoulou-Daifoti Z. Behavioral sexual dimorphism in models of anxiety and depression due to changes in HPA axis activity. Neuropharmacology 2012, 62:436-445.
33. Kosten T.A., Zhang X.Y., Kehoe P. Infant rats with chronic neonatal isolation experience show decreased extracellular serotonin levels in ventral striatum at baseline and in response to cocaine. Brain Res. Dev. Brain Res. 2004, 152:19-24.
34. Leventhal A.M., Brightman M., Ameringer K.J., Greenberg J., Mickens L., Ray L.A., Sun P., Sussman S. Anhedonia associated with stimulant use and dependence in a population-based sample of American adults. Exp. Clin. Psychopharmacol. 2010, 18:562-569.
35. Liechti M.E., Gamma A., Vollenweider F.X. Gender differences in the subjective effects of MDMA. Psychopharmacology (Berl.) 2001, 154:161-168.
36. Llorente R., Arranz L., Marco E.M., Moreno E., Puerto M., Guaza C., De la Fuente M., Viveros M.P. Early maternal deprivation and neonatal single administration with a cannabinoid agonist induce long-term sex-dependent psychoimmunoendocrine effects in adolescent rats. Psychoneuroendocrinology 2007, 32:636-650.
37. Llorente R., O'Shea E., Gutierrez-Lopez M.D., Llorente-Berzal A., Colado M.I., Viveros M.P. Sex-dependent maternal deprivation effects on brain monoamine content in adolescent rats. Neurosci. Lett. 2010, 479:112-117.
38. Llorente R., Miguel-Blanco C., Aisa B., Lachize S., Borcel E., Meijer O., Ramirez M.J., De Kloet E.R., Viveros M.P. Long term sex-dependent psychoneuroendocrine effects of maternal deprivation and juvenile unpredictable stress in rats. J. Neuroendocrinol. 2011, 23:329-344.
39. Llorente-Berzal A., Fuentes S., Gagliano H., López-Gallardo M., Armario A., Viveros M.P., Nadal R. Sex-dependent effects of maternal deprivation and adolescent cannabinoid treatment on adult rat behaviour. Addict. Biol. 2011, 16:624-637.
40. Llorente-Berzal A., Mela V., Borcel E., Valero M., López-Gallardo M., Viveros M.P., Marco E.M. Neurobehavioral and metabolic long-term consequences of neonatal maternal deprivation stress and adolescent olanzapine treatment in male and female rats. Neuropharmacology 2012, 62:1332-1341.
41. López-Gallardo M., López-Rodríguez A.B., Llorente-Berzal A., Rotllant D., Mackie K., Armario A., Nadal R., Viveros M.P. Maternal deprivation and adolescent cannabinoid exposure impact hippocampal astrocytes, CB1 receptors and brain-derived neurotrophic factor in a sexually dimorphic fashion. Neuroscience 2012, 204:90-103.
42. Manzanedo C., Rodríguez-Arias M., Daza-Losada M., Maldonado C., Aguilar M.A., Miñarro J. Effect of the CB1 cannabinoid agonist WIN 55212-2 on the acquisition and reinstatement of MDMA-induced conditioned place preference in mice. Behav. Brain Funct. 2010, 6:19.
43. Marco E.M., Adriani W., Llorente R., Laviola G., Viveros M.P. Detrimental psychophysiological effects of early maternal deprivation in adolescent and adult rodents: altered responses to cannabinoid exposure. Neurosci. Biobehav. Rev. 2009, 33:498-507.
44. Marco E.M., Valero M., de la Serna O., Aisa B., Borcel E., Ramirez M.J., Viveros M.P. Maternal deprivation effects on brain plasticity and recognition memory in adolescent male and female rats. Neuropharmacology 2012, 10.1016/j.neuropharm.2012.08.014.
45. Martini M., Valverde O. A single episode of maternal deprivation impairs the motivation for cocaine in adolescent mice. Psychopharmacology (Berl.) 2012, 219:149-158.
46. Matthews K., Robbins T.W., Everitt B.J., Caine S.B. Repeated neonatal maternal separation alters intravenous cocaine self-administration in adult rats. Psychopharmacology (Berl.) 1999, 141:123-134.
47. Mitsushima D., Masuda J., Kimura F. Sex differences in the stress induced release of acetylcholine in the hippocampus and corticosterone from the adrenal cortex in rats. Neuroendocrinology 2003, 78:234-240.
48. Moffett M.C., Harley J., Francis D., Sanghani S.P., Davis W.I., Kuhar M.J. Maternal separation and handling affects cocaine self-administration in both the treated pups as adults and the dams. J. Pharmacol. Exp. Ther. 2006, 317:1210-1218.
49. Nawata Y., Hiranita T., Yamamoto T. A cannabinoid CB(1) receptor antagonist ameliorates impairment of recognition memory on withdrawal from MDMA (Ecstasy). Neuropsychopharmacology 2010, 35:515-520.
50. Pálenícek T., Votava M., Bubeníková V., Horácek J. Increased sensitivity to the acute effects of MDMA ("ecstasy") in female rats. Physiol. Behav. 2005, 86:546-553.
51. Piazza P.V., Maccari S., Deminière J.M., Le Moal M., Mormède P., Simon H. Corticosterone levels determine individual vulnerability to amphetamine self-administration. Proc. Natl. Acad. Sci. U.S.A 1991, 88:2088-2092.
52. Sarkar S., Schmued L. Neurotoxicity of ecstasy (MDMA): an overview. Curr. Pharm. Biotechnol. 2010, 11:460-469.
53. Schechter M.D. Effect of MDMA neurotoxicity upon its conditioned place preference and discrimination. Pharmacol. Biochem. Behav. 1991, 38:344-539.
54. Schmidt C.J., Levin J.A., Lovenberg W. In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain. Biochem. Pharmacol. 1987, 36(5):747-755.
55. Schramm-Sapyta N.L., Walker Q.D., Caster J.M., Levin E.D., Kuhn C.M. Are adolescents more vulnerable to drug addiction than adults? Evidence from animal models. Psychopharmacology (Berl.) 2009, 206:1-21.
56. Segarra A.C., Agosto-Rivera J.L., Febo M., Lugo-Escobar N., Menéndez-Delmestre R., Puig-Ramos A., Torres-Diaz Y.M. Estradiol: a key biological substrate mediating the response to cocaine in female rats. Horm. Behav. 2010, 58:33-43.
57. Shalev U., Erb S., Shaham Y. Role of CRF and other neuropeptides in stress-induced reinstatement of drug seeking. Brain Res. 2010, 1314:15-28.
58. Shire D., Carillon C., Kaghad M., Calandra B., Rinaldi-Carmona M., Le Fur G., Caput D., Ferrara P. An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing. J. Biol. Chem. 1995, 270:3726-3731.
59. Silverman J.L., Koenig J.I. Evidence of the involvement of Erbeta an RGS9-2 in 17-beta estradiol enhancement of amphetamine-induced place preference behavior. Horm. Behav. 2007, 52:146-155.
60. Smith J.T., Waddell B.J. Developmental changes in plasma leptin and hypothalamic leptin receptor expression in the rat: peripubertal changes and the emergence of sex differences. J. Endocrinol. 2003, 176:313-319.
61. Suárez J., Llorente R., Romero-Zerbo S.Y., Mateos B., Bermúdez-Silva F.J., de Fonseca F.R., Viveros M.P. Early maternal deprivation induces gender-dependent changes on the expression of hippocampal CB(1) and CB(2) cannabinoid receptors of neonatal rats. Hippocampus 2009, 19:623-632.
62. Twitchell W., Brown S., Mackie K. Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons. J. Neurophysiol. 1997, 78:43-50.
63. Tzschentke T.M. Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog. Neurobiol. 1998, 56:613-672.
64. Valle F.P., Bols R.J. Age factors in sex differences in open-field activity of rats. Learn. Behav. 1976, 4:457-460.
65. Vázquez D.M., Eskandari R., Zimmer C.A., Levine S., López J.F. Brain 5-HT receptor system in the stressed infant rat: implications for vulnerability to substance abuse. Psychoneuroendocrinology 2002, 27:245-272.
66. Verheyden S.L., Hadfield J., Calin T., Curran H.V. Sub-acute effects of MDMA (+/- 3,4-methylenedioxymethamphetamine, ecstasy) on mood: evidence of gender differences. Psychopharmacology (Berl.) 2002, 161:23-31.
67. Vicentic A., Francis D., Moffett M., Lakatos A., Rogge G., Hubert G.W., Harley J., Kuhar M.J. Maternal separation alters serotonergic transporter densities and serotonergic 1A receptors in rat brain. Neuroscience 2006, 140:355-365.
68. Vidal-Infer A., Roger-Sanchez C., Daza-Losada M., Rodríguez-Arias M., Miñarro J., Aguilar M.A. Role of the dopaminergic system in the acquisition, expression and reinstatement of MDMA-induced conditioned place preference in adolescent mice. PLoS ONE 2012, 7(8):e43107.
69. Viveros M.P., Llorente R., López-Gallardo M., Suarez J., Bermúdez-Silva F., De la Fuente M., Rodriguez de Fonseca F., Garcia-Segura L.M. Sex-dependent alterations in response to maternal deprivation in rats. Psychoneuroendocrinology 2009, 34:S217-S226.
70. Viveros M.P., Díaz F., Mateos B., Rodríguez N., Chowen J.A. Maternal deprivation induces a rapid decline in circulating leptin levels and sexually dimorphic modifications in hypothalamic trophic factors and cell turnover. Horm. Behav. 2010, 57:405-414.
71. Viveros M.P., Llorente R., Díaz F., Romero-Zerbo S.Y., Bermudez-Silva F.J., Rodríguez de Fonseca F., Argente J., Chowen J.A. Maternal deprivation has sexually dimorphic long-term effects on hypothalamic cell-turnover, body weight and circulating hormone levels. Horm. Behav. 2010, 58:808-819.
72. Viveros M.P., Marco E.M., López-Gallardo M., Garcia-Segura L.M., Wagner E.J. Framework for sex differences in adolescent neurobiology: a focus on cannabinoids. Neurosci. Biobehav. Rev. 2011, 35:1740-1751.
73. Walker Q.D., Williams C.N., Jotwani R.P., Waller S.T., Francis R., Kuhn C.M. Sex differences in the neurochemical and functional effects of MDMA in Sprague-Dawley rats. Psychopharmacology (Berl.) 2007, 189:435-445.
74. Wallinga A.E., Grahlmann C., Granneman R.A., Koolhaas J.M., Buwalda B. Gender differences in hyperthermia and regional 5-HT and 5-HIAA depletion in the brain following MDMA administration in rats. Brain Res. 2011, 1398:13-20.
75. Zarrindast M.R., Nouri M., Ahmadi S. Cannabinoid CB1 receptors of the dorsal hippocampus are important for induction of conditioned place preference (CPP) but do not change morphine CPP. Brain Res. 2007, 1163:130-137.